Bouma, Peter Hermanus. et al.Download PDFPatent Trials and Appeals BoardJul 28, 202013264231 - (D) (P.T.A.B. Jul. 28, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/264,231 10/13/2011 Peter Hermanus Bouma 2009P00105WOUS 1081 24737 7590 07/28/2020 PHILIPS INTELLECTUAL PROPERTY & STANDARDS 465 Columbus Avenue Suite 340 Valhalla, NY 10595 EXAMINER PRAKASH, GAUTAM ART UNIT PAPER NUMBER 1799 NOTIFICATION DATE DELIVERY MODE 07/28/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): katelyn.mulroy@philips.com marianne.fox@philips.com patti.demichele@Philips.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte PETER HERMANUS BOUMA and MARTINUS LEONARDUS JOSEPHUS GEYSELAERS Appeal 2019-005234 Application 13/264,231 Technology Center 1700 ____________ Before JEFFREY T. SMITH, BEVERLY A. FRANKLIN, and AVELYN M. ROSS, Administrative Patent Judges. SMITH, Administrative Patent Judge. DECISION ON APPEAL Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1, 3–11, 15, and 17. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. STATEMENT OF THE CASE Claim 1 illustrates the subject matter on appeal and is reproduced below: 1 We use the word “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies the real party in interest as Koninklijke Philips N.V. Appeal Br. 2. Appeal 2019-005234 Application 13/264,231 2 1. A fluid chamber in a microfluidic device, the fluid chamber comprising: a wall having a first opening and a second opening adjacent to the first opening; and a single protrusion connected to the wall between the first opening and the second opening, the protrusion projecting inwardly from the wall, wherein the first opening is in fluid communication with a first channel to provide an inlet for fluids into the fluid chamber, wherein the second opening is in fluid communication with a second channel to provide an outlet for fluids out of the fluid chamber, and wherein the protrusion is substantially rounded, and is configured to control a propagation of the fluids from the first opening to the second opening enabling the fluids to substantially fill the fluid chamber before the fluids are pushed out of the second opening, and to increase an ability for the fluids to follow a surface of the wall. Appeal Br. 13, Claims Appendix. Claims 1, 3–8, 10, 15, and 17 stand rejected under 35 U.S.C. § 103 as unpatentable over Ulmanella et al. (US 2007/0280856 A1; published Dec. 6, 2007). Claims 9 and 11 stand rejected under 35 U.S.C. § 103 as unpatentable over Ulmanella et al. in view of Nurse et al. (US 2008/0163945 A1; published July 10, 2008).2 2 The complete statement of the rejection on appeal appears in the Final Office Action. (Final Act. 3–8). Appeal 2019-005234 Application 13/264,231 3 OPINION3 After review of the respective positions the Appellant presents in the Appeal Brief and the Examiner presents in the Final Office Action and the Answer, we determine that Appellant has not identified reversible error in the Examiner’s determination that the applied prior art would have rendered the subject matter recited in claims 1, 3–8, 10, 15, and 17 obvious to one of ordinary skill in the art within the meaning of 35 U.S.C. § 103. Accordingly, we sustain the Examiner’s § 103 rejections of the above claims for the reasons set forth in the Final Action and the Answer. We add the following for emphasis. We incorporate the findings and discussions presented in our prior decision on appeal for application 13/264,231, Appeal 2017–006792 mailed August 23, 2018. (hereinafter “Decision”) The Examiner finds Ulmanella teaches a fluid chamber in a microfluidic device, the fluid chamber comprising a wall having a first opening that is in fluid communication with a first channel to provide an inlet into the fluid chamber and a second opening that is in fluid communication with a second channel to provide an outlet for fluids out of the fluid chamber. (Final Act. 4.) The Examiner finds Ulmanella teaches Figure 5A depicts substantially rounded protrusions that project into the fluid chamber. (Final Act. 4.) The Examiner finds Ulmanella teaches, in a different embodiment, first and second openings that are adjacent to each other. (Final Act. 4; see also Ulmanella ¶ 88, Figures 16A and 16B.) The 3 Appellant presents substantive arguments addressing claims 1, 3–11, 15, and 17 together. (Appeal Br. 6–10.) We limit our discussion to independent claim 1 as representative of the subject matter on appeal. Appeal 2019-005234 Application 13/264,231 4 Examiner determines it would have been obvious to form a microfluidic device, such as described by Ulmanella Figure 5A, wherein the first and second openings are adjacent to each other such as depicted by Figures 16A and 16B. (Final Act. 4.) The Examiner further determines it would have been obvious to form a microfluidic device, such as described by Ulmanella, having a single projection between the first and second openings. (Final Act. 4.) Appellant argues Ulmanella in all of the embodiments where the inlet channel and outlet channel are not 180 degrees apart from one another —FIGs. 16A, 16B, 17A, and 17C—the chamber does not does not include any protrusions projecting inwardly. (Appeal Br. 7.) Appellant argues these embodiments are directed to the use of dried reagent Rs to control the flow of fluid through the chamber. (Appeal Br. 7.) Appellant’s arguments are not persuasive of reversible error. These arguments do not address the Examiner’s position as set forth in the rejection. (Final Act. 4–5.) Moreover, the issue regarding the location of the inlet and outlet channels and a microfluidic device adjacent to one another was expressly discussed in our prior decision. (Decision 8–9.) Ulmanella Figure 5A was cited for teaching a microfluidic device comprising substantially rounded protrusions that project into the fluid chamber. Ulmanella expressly discloses the location of the inlet and outlet channels can be modified. Specifically, Ulmanella states “[t]o achieve desired filling of the sample chamber, therefore, regions where the inlet and/or outlet channels join the sample chamber may be modified.” (Ulmanella ¶ 90.) The reference to Ulmanella Figures 16A–B, 17B–C was for the purpose of further evidence that it was known and, therefore, obvious Appeal 2019-005234 Application 13/264,231 5 that the location of the inlet and outlet channel could have been located in various positions of the microfluidic device. (Decision 9.) Our prior decision expressly acknowledged that the depictions of Ulmanella Figures 16A–B, 17A, and l7C was directed to an alternative embodiment. Appellant argues that the functional language “wherein the protrusion . . . is configured to control a propagation of the fluids from the first opening to the second opening enabling the fluids to substantially fill the fluid chamber before the fluids are pushed out of the second opening” should be considered in determining patentability and is otherwise not taught by Ulmanella. (Appeal Br. 8.) Appellant further argues the mere existence of protrusions is not sufficient to teach the claimed propagation control of the fluids from the first opening to the second opening, which is also dependent on positioning. (Reply Br. 7.) These arguments are not persuasive of reversible error. The Examiner properly determined it would have been obvious to form a microfluidic device, such as described by Ulmanella, having a single projection between the first and second openings. Ulmanella expressly teaches: Those skilled in the art would recognize that the shape, arrangement, dimensions, orientation, spacing, position within the chamber, and number of projecting members, grooves, reliefs or other features may vary and may be selected based on various factors, including, but not limited to, for example, improvement in fluidic performance (e.g., reduction in bubble entrapment), liquid and/or surface physicochemical properties, geometry of the chamber (surface roughness, shape, nonuniformities), filling conditions (flow rates, pressure differentials, centrifugal/centripetal forces due to centrifugal filling), orientation of the device, kinematic or dynamic status of the device, manufacturing constraints, and/or the ability to perform desired optical detection of the chamber. Appeal 2019-005234 Application 13/264,231 6 (Ulmanella ¶ 88.) Appellant has not directed us to objective evidence that establishes the projections within the microfluidic device operate in a manner that provides unexpected results in light of the express teachings of Ulmanella. Appellant has failed to direct us to objective evidence that establishes the argued functional language establishes a patently distinct invention. Based on our consideration of the totality of the record before us, and having evaluated the presented case of obviousness in view of Appellant’s arguments, we conclude that the preponderance of evidence weighs in favor of obviousness of the claimed subject matter within the meaning of § 103. See In re Oetiker, 977 F.2d 1443, 1445 (Fed. Cir. 1992). CONCLUSION In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1, 3–8, 10, 15, 17 103 Ulmanella 1, 3–8, 10, 15, 17 9, 11 103 Ulmanella, Nurse 9, 11 Overall Outcome 1, 3–11, 15, 17 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation